Home
DEI BioPharma Ltd

DEI BioPharma Ltd Market Share Analysis for August 2026

Discover why Africa is emerging as a top destination for pharmaceutical manufacturing - and how Dei Biopharma is leading Uganda’s charge to supply high-quality, affordable medicines globally.

Industry: N/A

Domaindeibiopharma.com

Year Founded2022

Employees201 - 500

Annual Revenue--

DEI BioPharma Ltd

DEI BioPharma Ltd (including company regionals)

deibiopharma.com

See more website traffic and engagement information

Total visits to DEI BioPharma Ltd's top domains

Understand DEI BioPharma Ltd market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

deibiopharma.com1.3K

See more with Sales Intelligence

Avg. visit duration in DEI BioPharma Ltd's top domains

Analyze DEI BioPharma Ltd engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

deibiopharma.com00:00:28

See more with Sales Intelligence

Avg. pageviews on DEI BioPharma Ltd's top domains

See how DEI BioPharma Ltd keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

deibiopharma.com3.92

See more with Sales Intelligence

DEI BioPharma Ltd top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by DEI BioPharma Ltd

These are the website technologies, by industry, used by DEI BioPharma Ltd top domains

Widget (4)

Twemoji

Payment & Currencies (3)

PayPal

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

6

See all

News & Signals from DEI BioPharma Ltd

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDei BioPharma Ltd. expanded facilities to Kampala, Uganda, Eastern Africa, Africa on Aug 10th '26.KAMPALA - A committee of Ugandan MPs has called on the government to urgently release the $430m that the biotechnology firm Dei BioPharma says it needs to finish its drug and vaccine plant near Kampala, arguing that the money would create jobs, cut the country's medicine import bill and eventually put treatments for diseases such as cancer and sickle cell within reach of ordinary patients.

NewsDei BioPharma Ltd. expands facilities to Uganda, Eastern Africa, Africa.Dei Biopharma opens a $50 million cassava plant in Namasagali, Kamuli (Uganda).

NewsDei BioPharma Ltd. increases headcount by 40000.DEI BioPharma expects to create over 40,000 jobs, providing a major boost to Uganda's scientific talent base, manufacturing sector, and overall economy.